Evidence map›Paper›PMID 42761510›Full record

ArticleAJPM focus2026

Mobilizing Community-Driven Public Health: Increasing Access to Diagnostic Testing for Underserved Individuals Through Lab-In-A-Van Partnerships.

Brittany L Choate, Ruhani Sardana, Acsah Mathews, Stephanie Weirsman, Katherine Fajardo, Yasmine Ali, Chen Liu, Pei Hui, Kevin Schofield, Anne L Wyllie and 1 more

Abstract read
In one paragraph

Article in AJPM focus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Brittany L ChoateSalivaDirect, Inc., New Haven, Connecticut.
Ruhani SardanaHospital of University of Pennsylvania, Philadelphia, Pennsylvania.
Acsah MathewsSalivaDirect, Inc., New Haven, Connecticut.
Stephanie WeirsmanYale Pathology Labs, Yale School of Medicine, Yale University, New Haven, Connecticut.
Katherine FajardoDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, Yale University, New Haven, Connecticut.
Yasmine AliSalivaDirect, Inc., New Haven, Connecticut.
Chen LiuYale Pathology Labs, Yale School of Medicine, Yale University, New Haven, Connecticut.
Pei HuiYale Pathology Labs, Yale School of Medicine, Yale University, New Haven, Connecticut.
Kevin SchofieldYale Pathology Labs, Yale School of Medicine, Yale University, New Haven, Connecticut.
Anne L WyllieDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, Yale University, New Haven, Connecticut.
Angelique W LeviYale Pathology Labs, Yale School of Medicine, Yale University, New Haven, Connecticut.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Underrepresented populations, who often have the highest need for accessible health care, frequently face barriers to accessing services. To address health inequities, researchers evaluated a community-informed lab-in-a-van model that was designed to increase access to COVID-19 testing for vulnerable populations. Methods: Free saliva-based SARS-CoV-2 diagnostic testing was offered between June 2023 and July 2024 at 123 events in Connecticut, U.S., using a Clinical Laboratory Improvement Amendments-certified mobile laboratory. Approximately 100 local leaders and organizations informed the program's design. After providing samples, participants completed an IRB-approved survey; responses were stored using REDCap. Results: Offering on-site testing helped remove barriers and increased access for traditionally underserved communities. Overall, 1,428 individuals were tested, and 838 completed a testing experience survey. Of the respondents, 54% identified as Black, Indigenous, People of Color; 59% reported an annual household income <$25,000; and 31% were uninsured. Participants reported that the service was easy to access (74%) and comfortable to use (75%); 29% received their first COVID-19 test, and 48% were unaware of alternative testing options. Results were reported in an average of 3.1 hours, enabling many participants to receive their diagnostic results during the community event; 48 positive samples were identified. Conclusions: This program evaluation demonstrates that community-informed mobile testing programs capable of delivering same-day diagnostic results can expand access to testing among underserved populations and may represent a scalable strategy for improving diagnostic access during future public health emergencies.

Indexed as

community engagementDiagnosticsepidemiologyhealth equitymobile testingSARS-CoV-2

Identifiers

PMID42761510
PMCPMC13586713

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.